Tirzepatide + B12 5mg/0.5mg/mL (2mL Vial)
- An injectable tirzepatide + vitamin B12 formulation available as a provider-guided weight-management treatment option.
- Treatment requires review by a licensed healthcare provider and a prescription when clinically appropriate.
Tirzepatide acts on GIP and GLP-1 receptors and may be used as part of a provider-guided weight-management treatment plan. This product also contains vitamin B12 and should be evaluated by a licensed provider for individual appropriateness.
Use this injectable treatment exactly as prescribed and follow the administration and storage instructions provided with your medication. Do not change the amount or schedule without guidance from your healthcare provider.
Tirzepatide may cause gastrointestinal effects such as nausea, diarrhea, vomiting, constipation, or abdominal discomfort. Your provider should review your health history, medications, potential interactions, and other safety considerations before treatment
Your licensed healthcare provider determines whether this treatment is appropriate for you and provides guidance on its use, monitoring, and ongoing treatment decisions based on your individual health needs
Start Your Tirzepatide
Care Journey
A simple provider-guided process to determine whether tirzepatide + B12 may be appropriate for your weight-management needs.
- 1Get Started
A licensed provider reviews your information and determines whether this treatment is clinically appropriate for you.
Quick online process
- 2Provider Review
A licensed provider reviews your information and determines whether this treatment is clinically appropriate.
Prescription required
- 3Receive Your Treatment
If prescribed, your medication is prepared and delivered with instructions for your prescribed treatment plan.
Discreet delivery available
- 4Continue Your Care
Follow your prescribed treatment plan and work with your provider as your weight-management needs are reviewed over time.
Provider-guided care
Everything You Need
Starting Treatment
Review key considerations about this formulation, injectable treatment, safety, and ongoing weight-management care.
- Understanding the Tirzepatide Component
- Understanding the Vitamin B12 Component
- Injection Measurement and Administration
- Health Conditions and Medication Considerations
- Recognizing Concerning Treatment Reactions
- When Your Provider May Reassess Treatment
This formulation may be compounded and is not FDA-approved. Compounded drugs are not reviewed by FDA for safety, effectiveness, or quality before marketing. Treatment suitability and administration instructions should be determined by a licensed healthcare provider
Explore More
Treatment Options
Explore other weight-management options available through provider-guided care and review which treatment may be appropriate for your needs.
SEMAGLUTIDE ODT 10MG
Starts atFrom $99/moPrescription requiredSEMAGLUTIDE/B12 0.6 MG/ 500 MCG/ML (2 ML)
Starts atFrom $99/moPrescription requiredOral Tirzepatide 5mg
Starts atFrom $99/moPrescription requiredTirzepatide + B12 Injection 5mg/0.5mg/mL (you’re viewing this)
Starts atFrom $99/moPrescription required
Your Tirzepatide + B12
Care Plan
Your provider guides your treatment approach based on your health needs and response over time.
If prescribed, your provider will provide instructions for beginning treatment and using your medication as directed.
Use your medication according to your prescription and follow the administration, storage, and treatment instructions provided.
Your provider may review your response and treatment experience to determine the appropriate next step in your care.
Treatment plans, dosage, administration instructions, and any adjustments vary by patient and are determined by your healthcare provider. Do not change your treatment or dosage without provider guidance.
Frequently Asked Questions
Tirzepatide + B12 5mg/0.5mg/mL is an injectable formulation containing tirzepatide and vitamin B12. It may be considered as part of a provider-guided weight-management treatment plan when clinically appropriate.
This formulation combines tirzepatide with vitamin B12. The presence of vitamin B12 does not by itself establish that the combination is safer or more effective for weight management. Your healthcare provider should determine whether this specific formulation is appropriate for you.
This specific compounded tirzepatide + B12 formulation is not FDA-approved. FDA states that compounded drugs are not reviewed for safety, effectiveness, or quality before they are marketed. FDA-approved tirzepatide products are specific approved formulations and should not be represented as interchangeable with a compounded formulation.
Yes. Treatment requires evaluation by a licensed healthcare provider and a prescription when the provider determines that the treatment is clinically appropriate for you.
Tirzepatide can cause gastrointestinal effects such as nausea, diarrhea, vomiting, constipation, and abdominal discomfort. More serious risks can also occur, so your provider should review your health history, medications, contraindications, and other safety considerations before treatment. FDA has received reports of adverse events associated with compounded tirzepatide, although an individual report does not necessarily establish that the drug caused the event.
This product may be a compounded medication and is not FDA-approved. Treatment suitability, dosage, administration, and ongoing care are determined by a licensed healthcare provider based on individual clinical circumstances.